Development and Characterization of Synthetic Norovirus RNA for Use in Molecular Detection Methods
Annals of Laboratory Medicine · 01.01.2023 · 43 (1) · 38-44
DOI: 10.3343/alm.2023.43.1.38 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Laboratory Medicine, online erschienen am 01.09.2022. Verfasst von Eun-Jung Cho und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Hallym University College of Medicine, Chuncheon, Korea. Hauptthemen laut MEDLINE: Caliciviridae Infections, Norovirus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Food and Drug Safety.
Abstract (Originalsprache)
Background
Reference materials are essential for the quality assurance of molecular detection methods. We developed and characterized synthetic norovirus GI and GII RNA reference materials.
Methods
Norovirus GI and GII RNA sequences including the ORF1-ORF2 junction region were designed based on 1,495 reported norovirus sequences and synthesized via plasmid preparation and in vitro transcription. The synthetic norovirus GI and GII RNAs were evaluated using six commercial norovirus detection kits used in Korea and subjected to homogeneity and stability analyses. A multicenter study involving five laboratories and using four commercial real-time PCR norovirus detection assays was conducted for synthetic norovirus RNA characterization and uncertainty measurements.
Results
The synthetic norovirus GI and GII RNAs were positively detected using the six commercial norovirus detection kits and were homogeneous and stable for one year when stored at -20°C or -70°C. All data from the five laboratories were within a range of 1.0 log copies/μL difference for each RNA, and the overall mean concentrations for norovirus GI and GII RNAs were 7.90 log copies/μL and 6.96 log copies/μL, respectively.
Conclusions
The synthetic norovirus GI and GII RNAs are adequate for quality control based on commercial molecular detection reagents for noroviruses with high sequence variability. The synthetic RNAs can be used as reference materials in norovirus molecular detection methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Hallym University College of Medicine, Chuncheon, Korea.
- Molecular Diagnostic R&D Center, Bioneer, Daejeon, Korea.
- Department of Laboratory Medicine, Veterans Health Service Medical Center, Seoul, Korea.
- Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
- Department of Laboratory Medicine, Dongguk University Ilsan Hospital, Ilsan, Korea.
- Corporate R&D Center for Biological Standards and Control, Resources and Innovation Cooperative, Hanam, Korea.
ORCID-Profile: Eun-Jung Cho, Younggil Cha, Su Kyung Lee, Han-Sung Kim, Jae-Seok Kim, Eun Jin Lee, Nuri Lee, Ki Ho Hong, Hee Jin Huh, Young Joo Cha, Hyun Soo Kim
Förderung
- Ministry of Food and Drug Safety
Zitieren
APA
Cho, E. J., Cha, Y., Lee, S. K., Kim, H. S., Kim, J. S., Lee, E. J., Lee, N., Hong, K. H., Huh, H. J., Cha, Y. J., & Kim, H. S. (2023). Development and Characterization of Synthetic Norovirus RNA for Use in Molecular Detection Methods. Annals of Laboratory Medicine, 43(1), 38-44. https://doi.org/10.3343/alm.2023.43.1.38
Vancouver
Cho EJ, Cha Y, Lee SK, Kim HS, Kim JS, Lee EJ, et al. Development and Characterization of Synthetic Norovirus RNA for Use in Molecular Detection Methods. Annals of Laboratory Medicine. 2023;43(1):38-44. doi:10.3343/alm.2023.43.1.38
BibTeX
@article{Cho2023,
author = {Cho, Eun-Jung and Cha, Younggil and Lee, Su Kyung and Kim, Han-Sung and Kim, Jae-Seok and Lee, Eun Jin and Lee, Nuri and Hong, Ki Ho and Huh, Hee Jin and Cha, Young Joo and Kim, Hyun Soo},
title = {Development and Characterization of Synthetic Norovirus RNA for Use in Molecular Detection Methods},
journal = {Annals of Laboratory Medicine},
year = {2023},
volume = {43},
number = {1},
pages = {38--44},
doi = {10.3343/alm.2023.43.1.38}
}
EUVIMED